CNS Pharmaceuticals prices $1.37M registered direct offering and private placement

CNS Pharmaceuticals, Inc.

Offering of 366,000 shares (or pre-funded warrants) at $3.75/share, with common warrants exercisable at $3.62.
Gross proceeds expected $1.37M; net proceeds for working capital and general corporate purposes.
Closing expected on or about June 17, 2024, subject to customary closing conditions.
Warrants expire 5 years from issuance; cashless exercise if no effective registration statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.